Literature DB >> 8082751

Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections.

O Cussenot1, P Berthon, B Cochand-Priollet, N J Maitland, A Le Duc.   

Abstract

By analyzing a culture system of human prostatic epithelial cells (HPEC) and human prostatic fibroblasts (HPF) for expression of several determinants by immunocytochemistry, we have shown that long-term cultures are able to preserve the phenotypic characteristics of the normal tissue from which they are derived. The cytoskeletal elements, prostate-specific proteins, and steroid receptor profiles were compared to those of prostatic epithelium and stroma in situ. When cultured in low serum and low calcium medium, the adult HPEC grew as two layers of cells, the upper one of which retained the differentiation characteristics observed in the luminal fraction of normal prostatic epithelium. This cell type is the likely origin of prostatic neoplasia, with expression of CK8, 18, and 19 but not CK14. Androgen receptors, prostatic-specific antigen, and prostatic acid phosphatase are also expressed in vitro but at lower level than in situ. The lower cell layer expressed most of the same determinants but at a much lower level, suggestive of a stem-cell type. The HPF cultured in RPMI serum supplemented media retained the stromal pattern of the cells observed in situ. Culture systems which conserve the characteristics of their normal counterparts in vivo should provide useful models for studying in vitro genetic and epigenetic factors associated with differentiation and proliferation, but also with tumorigenic progression in the prostatic gland.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082751     DOI: 10.1006/excr.1994.1236

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium.

Authors:  M Stanbrough; I Leav; P W Kwan; G J Bubley; S P Balk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

2.  A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids.

Authors:  Martin L Read; Surjeet Singh; Zubair Ahmed; Mark Stevenson; Simon S Briggs; David Oupicky; Lee B Barrett; Rachel Spice; Mark Kendall; Martin Berry; Jon A Preece; Ann Logan; Leonard W Seymour
Journal:  Nucleic Acids Res       Date:  2005-05-24       Impact factor: 16.971

3.  Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.

Authors:  H J Chen; A T Treweeke; Y Q Ke; D C West; C H Toh
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

4.  Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.

Authors:  Xiang Xu; Yu-Hua Huang; Yan-Jing Li; Alexa Cohen; Zhen Li; Jill Squires; Wei Zhang; Xu-Feng Chen; Min Zhang; Jiao-Ti Huang
Journal:  Asian J Androl       Date:  2017 Nov-Dec       Impact factor: 3.285

5.  Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells.

Authors:  Michelle Schmidt; Ananthi J Asirvatham; Jaideep Chaudhary
Journal:  Cell Mol Biol Lett       Date:  2010-02-25       Impact factor: 5.787

6.  The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Authors:  Charlie E Massie; Andy G Lynch; Rosalind A Eeles; Colin S Cooper; David C Wedge; Daniel S Brewer; Claudia Buhigas; Anne Y Warren; Wing-Kit Leung; Hayley C Whitaker; Hayley J Luxton; Steve Hawkins; Jonathan Kay; Adam Butler; Yaobo Xu; Dan J Woodcock; Sue Merson; Fiona M Frame; Atef Sahli; Federico Abascal; Iñigo Martincorena; G Steven Bova; Christopher S Foster; Peter Campbell; Norman J Maitland; David E Neal
Journal:  Mol Cancer       Date:  2022-09-22       Impact factor: 41.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.